» Articles » PMID: 35132530

Enucleated Oocyte Donation: First for Infertility Treatment, then for Mitochondrial Diseases

Overview
Publisher Springer
Date 2022 Feb 8
PMID 35132530
Authors
Affiliations
Soon will be listed here.
Abstract

There seems to be a consensus that enucleated oocyte donation (EOD) should only be used to reduce the risk of having a child with mitochondrial disorders. However, this paper argues that in the initial phase in which we are at the moment, EOD should first be used to remedy infertility caused by poor oocyte quality or poor embryonic development. That learning period will allow researchers to improve their technical skills and the knowledge of the best procedure before starting on high-risk cases. Mitochondrial carryover of pathologic mtDNA is the main cause of concern for the offspring. That risk does not exist in infertility cases. The application of EOD to treat infertility should at present be performed in a clinical research setting to obtain more evidence about efficacy and safety.

Citing Articles

Operation "mitochondrial wipeout" - clearing recipient mitochondria DNA during the cytoplasmic replacement therapy.

Kirillova A, Mazunin I J Assist Reprod Genet. 2022; 39(10):2205-2207.

PMID: 35852730 PMC: 9596630. DOI: 10.1007/s10815-022-02561-6.

References
1.
Zhang J, Liu H, Luo S, Lu Z, Chavez-Badiola A, Liu Z . Live birth derived from oocyte spindle transfer to prevent mitochondrial disease. Reprod Biomed Online. 2017; 34(4):361-368. DOI: 10.1016/j.rbmo.2017.01.013. View

2.
Tang M, Guggilla R, Gansemans Y, Van der Jeught M, Boel A, Popovic M . Comparative analysis of different nuclear transfer techniques to prevent the transmission of mitochondrial DNA variants. Mol Hum Reprod. 2019; 25(12):797-810. DOI: 10.1093/molehr/gaz062. View

3.
Tang M, Boel A, Castelluccio N, Cardona Barberan A, Christodoulaki A, Bekaert B . Human germline nuclear transfer to overcome mitochondrial disease and failed fertilization after ICSI. J Assist Reprod Genet. 2022; 39(3):609-618. PMC: 8995215. DOI: 10.1007/s10815-022-02401-7. View

4.
. Planned oocyte cryopreservation for women seeking to preserve future reproductive potential: an Ethics Committee opinion. Fertil Steril. 2018; 110(6):1022-1028. DOI: 10.1016/j.fertnstert.2018.08.027. View

5.
Provoost V, Tilleman K, DAngelo A, De Sutter P, de Wert G, Nelen W . Beyond the dichotomy: a tool for distinguishing between experimental, innovative and established treatment. Hum Reprod. 2014; 29(3):413-7. DOI: 10.1093/humrep/det463. View